Schedule 13G ownership disclosure

GALERA THERAPEUTICS INC

Security class unavailable · CUSIP: 36338D108

Event date: 2022-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,543,783
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-22-000175
Form type
SC 13G
Filer
Galera Therapeutics, Inc.
CIK
CIK 1563577
Filed
Feb 11, 2022
Reporting period
Feb 04, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub